Missed our latest free live-stream? Catch up now with Intracranial Enhancement by Frank Gaillard


Dr Tom Foster and Dr Rohit Sharma et al.

Neurocandidiasis results from disseminated infection of the central nervous system by the fungus Candida albicans, usually manifesting as cerebral micro-abscesses and meningitis.

CNS disease is thought to occur in up to 52% of patients with disseminated candidiasis, but predominates in immunocompromised individuals 1,2.

Risk factors include 1,2:

  • AIDS
  • prolonged high-dose corticosteroid use
  • neutropenia, especially in the setting of hematological malignancies
  • graft-vs-host disease after allogeneic bone marrow transplantation
  • neonates with recent neurosurgery
  • patients with CNS shunts and other devices

Patients with neurocandidiasis have a varied presentation, but most commonly exhibit symptoms akin to an acute or chronic bacterial meningitis, however these symptoms may be subtle or absent in neonates or severely neutropenic patients 1,2. Furthermore, in patients with multiple cerebral micro-abscesses, a diffuse encephalopathy may be the predominant clinical presentation, however this is also often subtle 1.

Neurocandidiasis most commonly results from disseminated hematogenous infection of Candida albicans, but can rarely also be due to other Candida spp. such as Candida parapsilosis, Candida tropicalis, and Candida glabrate 3. In addition to hematogenous spread to the CNS, Candida may also be introduced to the CNS during craniotomy or through the presence of a CNS shunt 3.

Once in the CNS, and due to their small size, Candida has a predilection for the microcirculation, classically resulting in multiple cerebral micro-abscesses and leptomeningitis 4. However, Candida can also uncommonly cause the development of mycotic aneurysms resulting in intracerebral hemorrhage or subarachnoid hemorrhage, thrombosis in small perforating arterioles resulting in ischemic stroke, cerebral macro-abscesses, and cerebral vasculitis 1,2.

The disease can have a variety of radiographic features, but the main two findings are 1,2:

CT findings can often be subtle and non-specific 1. The most common reported feature is secondary communicating hydrocephalus reflective of leptomeningitis, however this is still an uncommon finding seen in only 20% of cases 1,2. Micro-abscesses are very rarely appreciated on CT 1.

Micro-abscesses are the hallmark radiographic feature of neurocandidiasis 1,2. They are less than 3 mm in size, multiple, and most commonly located at the gray-white matter junction, basal ganglia, and/or cerebellum 1,5-9. These micro-abscesses have MR signal characteristics that are identical to other brain abscesses, those being classic ring-enhancing lesions with striking high signal intensity on DWI 1,5-9. Small hemorrhagic components are also commonly observed, which may demonstrate low signal intensity on T2-weighted images and may be better appreciated on GRE or SWI images 1,2,5.

In addition to secondary communicating hydrocephalus, MRI may reveal non-specific leptomeningeal enhancement on post-gadolinium images 1. However, this enhancement does not occur in any specific distribution making it therefore indistinguishable from bacterial leptomeningitis, and is also uncommonly reported 1.

As aforementioned, rarely neurocandidiasis can present with other clinico-radiological features:

Neurocandidiasis is treated with intravenous antifungal agents such as liposomal amphotericin B and flucytosine 1. Neurosurgical opinion and intervention may also be sought if CNS shunt infection is suspected 1. Mortality of neurocandidiasis is reported to be up to 30% 9.

General imaging differential considerations include:

Infections of the central nervous system

Article information

rID: 55117
Synonyms or Alternate Spellings:
  • CNS candidiasis
  • Central nervous system candidiasis
  • Cerebral candidiasis

ADVERTISEMENT: Supporters see fewer/no ads

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.